GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hubei Goto Biopharm Co Ltd (SZSE:300966) » Definitions » Gross-Profit-to-Asset %

Hubei Goto Biopharm Co (SZSE:300966) Gross-Profit-to-Asset % : 1.66% (As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Hubei Goto Biopharm Co Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Hubei Goto Biopharm Co's annualized Gross Profit for the quarter that ended in Sep. 2024 was ¥45.3 Mil. Hubei Goto Biopharm Co's average Total Assets over the quarter that ended in Sep. 2024 was ¥2,734.9 Mil. Therefore, Hubei Goto Biopharm Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Sep. 2024 was 1.66%.


Hubei Goto Biopharm Co Gross-Profit-to-Asset % Historical Data

The historical data trend for Hubei Goto Biopharm Co's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hubei Goto Biopharm Co Gross-Profit-to-Asset % Chart

Hubei Goto Biopharm Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross-Profit-to-Asset %
Get a 7-Day Free Trial 18.38 13.13 15.46 8.43 5.54

Hubei Goto Biopharm Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.36 6.25 4.28 2.18 1.66

Competitive Comparison of Hubei Goto Biopharm Co's Gross-Profit-to-Asset %

For the Biotechnology subindustry, Hubei Goto Biopharm Co's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hubei Goto Biopharm Co's Gross-Profit-to-Asset % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Hubei Goto Biopharm Co's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Hubei Goto Biopharm Co's Gross-Profit-to-Asset % falls into.



Hubei Goto Biopharm Co Gross-Profit-to-Asset % Calculation

Hubei Goto Biopharm Co's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=125.121/( (2069.305+2447.741)/ 2 )
=125.121/2258.523
=5.54 %

Hubei Goto Biopharm Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Sep. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Sep. 2024 )/( (Total Assets (Q: Jun. 2024 )+Total Assets (Q: Sep. 2024 ))/ count )
=45.348/( (2772.474+2697.253)/ 2 )
=45.348/2734.8635
=1.66 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Sep. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Hubei Goto Biopharm Co Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Hubei Goto Biopharm Co's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Hubei Goto Biopharm Co Business Description

Traded in Other Exchanges
N/A
Address
Gaokeng Group, Xiaohe Town, Hubei Province, Yicheng, CHN, 441002
Hubei Goto Biopharm Co Ltd is engaged in the research and development, production, and sales of steroidal hormone drug raw materials.
Executives
Li Ming Lei Directors, executives
Jiang Jian Jun Supervisors

Hubei Goto Biopharm Co Headlines

No Headlines